1[3]Fleckenstein J F, Paredes M, Thuluvath P J. A retrospective, randomized, duble-blind trial. evaluating the efficacy of ursodeoxycholic acid in prevention of liver transplant rejection[J]. Liver Transpl Surg, 1998, 4:276. 被引量：1
2Singh N. Infectious diseases in the liver transplant recipient. Semin Gastrointest Dis,1998,9:136-146. 被引量：1
3Arnow PM. Infections following orthotopic liver transplantation. Hepatobiliary Surg,1991,3:221-232. 被引量：1
4Garcia-Valdecasas JC, Prados M, Rimola A, et al. Risk factors for severe bacterial infection after liver transplantation. Transplant Proc,1995,27:2334-2335. 被引量：1
5Singh N, Gayowski T, Wagener MM, et al. Pulmonary infiltrates in liver transplant recipients in the intensive care unit. Transplantation,1999,67:1138-1144. 被引量：1
6Torres A, Ewig S, Insausti J, et al. Etiology and microbial patterns of pulmonary infiltrates in patients with orthotopic liver transplantation. Chest,2000,117:494-502. 被引量：1
2Jian-Dang Zhou, Jian-Jun Guo, Qin Zhang, Yin Chen, Shai-Hong Zhu and Huai-Yan Peng Department of Clinical Laboratory Institute of Organ Transplantation the Third Xiangya Hospital of Central South University,Department of Medical Laboratories College of Medical Technology and Information of Central South University, Changsha 410013, China.Drug resistance of infectious pathogens after liver transplantation[J].Hepatobiliary & Pancreatic Diseases International,2006,5(2):190-194. 被引量：3
